PrecisionLife is a pioneering techbio company committed to generating the deepest insights into chronic disease biology, which is a critical step in understanding which targets and drugs will work with which subgroups of patients.
Their approach to addressing unmet medical needs in chronic diseases is unique and innovative. They employ an AI-led Innovation Engine, powered by their unique combinatorial analytics, to stratify patient populations at the highest resolution. This allows them to find all the mechanistic drivers of disease for subgroups of patients.
In the realm of drug discovery, PrecisionLife has made significant strides. Their scalable platform has delivered the deepest disease insights in over 40 complex, chronic indications. They have one of the largest drug discovery pipelines of precision targeted therapies for unmet medical needs. Their high-resolution patient stratification identifies subgroups of patients with similar disease drivers and treatment responses, making precision medicine possible in chronic diseases.